CRMD Live signals | Maximize Profits with Getagraph.com

SELL 94286 min ago

@ $3.15

Issued: 14 Feb 2024 @ 09:32

Return: 67.62%

Previous signal: Feb 12 - 13:31

Previous signal: Buy

Return: -4.11 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	1.95M
Average Volume	564 062
Market Cap	289.41M
EPS	$0 ( 2024-03-12 )
Next earnings date	( $-0.280 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.21
ATR14	$0.0120 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-05	Lefkowitz Steven W	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Stewart Robert A	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Kaplan Myron	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Dillione Janet	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Dunton Alan W	Buy	30 000	Stock Option (Right to Buy Common Stock)

INSIDER POWER
93.18
Last 95 transactions
Buy: 4 530 513 \| Sell: 123 432

Volume Correlation

Long: 0.06 (neutral)

Short: -0.98 (very strong negative)

Signal:(60.398) Neutral

CorMedix Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CorMedix Inc Correlation - Currency/Commodity

0.34
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.43
( neutral )

-0.41
( neutral )

CorMedix Inc Financials

Annual	2022
Revenue:	$65 408.00
Gross Profit:	$61 674.00 (94.29 %)
EPS:	$-0.740

Q3	2023
Revenue:	$0
Gross Profit:	$-51 862.00 (0.00 %)
EPS:	$-0.170

Q2	2023
Revenue:	$0
Gross Profit:	$-50 748.00 (0.00 %)
EPS:	$-0.250

Q1	2023
Revenue:	$0
Gross Profit:	$-49 445.00 (0.00 %)
EPS:	$9.77

Financial Reports:

No articles found.

CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.